AOD 9604 targets only peripheral fat metabolism without affecting the GH axis, making it relevant to investigational protocols in which isolated lipolytic activity is the objective and systemic GH effects are not required
Though there has been some rudimentary research work indicating that the GLP-1 receptor agonists can indirectly provide mood-enhancing effects by regulating the dopamine reward system, lessening inflammatory responses, or improving metabolic status, adverse events that have been observed in real life studies and case reports can suggest that their action at the central nervous system is more complicated [11, 16, 17]
Always store unopened pens or vials in a refrigerator between 36F and 46F, never in the freezer
If your pharmacy dispenses vials without light-protective packaging, store them in a dark area of your refrigerator
The timeline has shifted somewhat later than originally projected BLA filing Q1 2027 rather than NDA Q4 2026 but the path is now fully mapped rather than dependent on trials still to come
By activating GLP-1 receptors, semaglutide slows stomach emptying, reduces appetite signals in the brain, and improves your body's own insulin secretionall three actions lower circulating glucose levels